Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Chlorpheniramine polistirex; codeine polistirex - Generic Drug Details

« Back to Dashboard

What are the generic sources for chlorpheniramine polistirex; codeine polistirex and what is the scope of chlorpheniramine polistirex; codeine polistirex patent protection?

Chlorpheniramine polistirex; codeine polistirex
is the generic ingredient in three branded drugs marketed by Fisons, Vernalis R And D Ltd, and Ucb Inc, and is included in three NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Chlorpheniramine polistirex; codeine polistirex has nineteen patent family members in fourteen countries.

There are twenty-nine drug master file entries for chlorpheniramine polistirex; codeine polistirex. One supplier is listed for this compound.

Summary for Generic Name: chlorpheniramine polistirex; codeine polistirex

Drug Master File Entries: see list29
Suppliers / Packagers: see list1
Clinical Trials: see list54
Drug Prices:see low prices
DailyMed Link:chlorpheniramine polistirex; codeine polistirex at DailyMed

Pharmacology for Ingredient: chlorpheniramine polistirex; codeine polistirex

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vernalis R And D Ltd
chlorpheniramine polistirex; codeine polistirex
SUSPENSION, EXTENDED RELEASE;ORAL207768-001Apr 30, 2015RXYesYes8,790,700► SubscribeY ► Subscribe
Ucb Inc
chlorpheniramine polistirex; codeine polistirex
SUSPENSION, EXTENDED RELEASE;ORAL021369-001Jun 21, 2004DISCNNoNo► Subscribe► Subscribe
Vernalis R And D Ltd
chlorpheniramine polistirex; codeine polistirex
SUSPENSION, EXTENDED RELEASE;ORAL207768-001Apr 30, 2015RXYesYes8,062,667► SubscribeY ► Subscribe
chlorpheniramine polistirex; codeine polistirex
SUSPENSION, EXTENDED RELEASE;ORAL018928-001Aug 14, 1985DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus